Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CERO THERAPEUTICS HOLDINGS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 153K | May 30, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNGTU | Range Capital Acquisition Corp II | Oct 2, 2025 | 0 | $0 | 3 | Oct 2, 2025 | Chief Financial Officer |
WINT | WINDTREE THERAPEUTICS INC /DE/ | Aug 3, 2025 | 0 | $0 | 3 | Aug 5, 2025 | Director |
CERO | CERO THERAPEUTICS HOLDINGS, INC. | May 30, 2025 | 1 | $0 | 4 | Jun 2, 2025 | Chief Financial Officer |
CERO | CERO THERAPEUTICS HOLDINGS, INC. | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Chief Financial Officer |
CERO | CERO THERAPEUTICS HOLDINGS, INC. | Oct 1, 2024 | 0 | $0 | 3 | Oct 2, 2024 | Chief Financial Officer |
CBRG | Chain Bridge I | Apr 1, 2024 | 0 | $0 | 3 | Apr 5, 2024 | Chief Financial Officer |